Cite
HARVARD Citation
Vittrup, I. et al. (2023). A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head‐and‐neck dermatitis. Journal of the European Academy of Dermatology and Venereology. pp. 1046-1055. [Online].